Subpoena involving AstraZeneca in the US

NYSE listed pharmacy chain Medco Health Solutions, Inc wrote in its Quarterly report SEC filing that it has received a subpoena earlier this month from the United States Department of Justice concerning its arrangements with AstraZeneca (LSE: AZN, OMXS: AZN, NYSE: AZN) over four of AstraZeneca’s drugs. According to reports the drugs in question are Nexium, Prilosec, Plendil and Toprol XL-Astra. Potential liabilities from drug-maker-pharmacy arrangements can be large. AstraZeneca is due to report quarterly earnings tomorrow morning.